You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Moodys
McKesson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Galt Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GALT PHARMS, and what generic alternatives to GALT PHARMS drugs are available?

GALT PHARMS has two approved drugs.

There is one US patent protecting GALT PHARMS drugs.

Summary for Galt Pharms
US Patents:1
Tradenames:3
Ingredients:2
NDAs:2

Drugs and US Patents for Galt Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms ORPHENGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-002 May 29, 1998 DISCN No No   Start Trial   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 RX Yes Yes 7,608,616   Start Trial   Start Trial
Galt Pharms ORPHENGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-001 May 29, 1998 DISCN No No   Start Trial   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 DISCN No No 7,608,616   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Galt Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 4,521,431   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 3,845,039   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 3,845,039   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 4,128,658   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 3,920,818   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 3,920,818   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Mallinckrodt
Dow
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.